Poster SESSIONS
59
Poster, 24 June 2014
Authors are asked to present their posters during the poster sessions.
P-21
POSTER SESSION
17:15–18:45
Hall B
Anxiety disorders B
P-21-001
Effect of curcumin on benzodiazepine re-
lated drugs-induced anxiety-related behav-
iors in mice
Ken-Ichi Tanaka, Koshigaya, Japan
A. Sakamoto, S. Sakai
P-21-002
Personality traits in patients with panic dis-
order
Ricardo Muotri, São Paulo, Brazil
M. Bernik
P-21-003
High baseline ‚anxiety‘ in male wistar rats
predicts an ‚anxiogenic‘ effect of an SSRI
which is dampened by subchronic SSRI
treatment
Jakob Näslund, Gothenburg, Sweden
E. Studer, H. Nissbrandt, E. Eriksson, O. Holm-
blad
P-21-004
Ultra-long-term outcome of panic disorder
with clonazepam or paroxetine: A random-
ized, open, systematic treatment for 3 years
and a follow-up for 6 years after
Antonio Nardi, Rio de Janeiro, Brazil
R. Freire, R. Amrein, S. Machado, A. Cardoso,
M. Mochcovitch, M. Versiani
P-21-005
The „anxiogenic“ effect of acute escitalo-
pram on startle behaviour, but not that of
contextual conditioning, is more pronounced
in wistar rats with high baseline reactivity
Robert Pettersson, Göteborg, Sweden
E. Eriksson, M. Hagsäter
P-21-006
Randomized, placebo-controlled effective-
ness study of Quetiapine XR in co-morbid
depressive and anxiety disorders
Arun V. Ravindran, Toronto, Ontario, Canada
G. Abraham, S. Johnson, R. Chandrasena
P-21-007
Afobazole increases binding of sigma-1 re-
ceptor selective agonist in P2 fraction of
CD-1 mice brain homogenate ex vivo
Elena Ryaskina, Moscow, Russia
M. Voronin, S. Seredenin
P-22
POSTER SESSION
17:15–18:45
Hall B
Bipolar disorders B
P-22-001
Prescription of antidepressants for bipolar
disorder: A retrospective study at Tokyo
Women´s Medical University
Hiroyuki Muraoka, Tokyo, Japan
K. Inada, T. Kawano, M. Kawano, T. Tsutsumi,
D. Hasegawa, J. Ishigooka
P-22-002
Patients‘ preference for treatment of bipolar
disorder: An internet survey
Kazuhiro Nozaki, Tokyo, Japan
T. Kikuchi, K. Watanabe
P-22-003
Affective switch under antidepressants: Re-
ality or fiction?
Karel Frasch, Donauwoerth, Germany
T. Becker
P-22-004
Korean medication algorithm project for bi-
polar disorder 2014: Rapid cycling
Jong-Hyun Jeong, Suwon, Republic of Korea
Y. M. Jae, D.-I. Jon, W.-M. Bahk
P-22-005
Effects of mood-stabilizing drugs on den-
dritic outgrowth and synaptic proteins levels
in the primary hippocampal neurons
Young Hoon Kim, Busan, Republic of Korea
S. W. Park, J. H. Lee, H. Y. Jo, C. H. Lee, M. K.
Seo, J. G. Lee, B. J. Lee, S. J. Lee
P-22-006
Efficacy of long-acting injectable antipsy-
chotics in the treatment of bipolar disorder
Shih-Ku Lin, Taipei, Taiwan
P-22-007
Impact on biomarkers of a comprehensive
rehabilitation program in bipolar disorder
(PRISMA): A multimodal approach
Carlos Lopez-Jaramillo, Medellin, Colombia
C. Vargas Upegui, S. Saldarriaga-Gomez,
M. Valencia-Escobar, J. D. Palacio, S. Ospina,
F. Kapczinski, E. Vieta
P-22-008
A preclinical model and human genetic
studies implicate abnormal development of
monoaminergic neurons in bipolar disorder
Vlado Jukic, Zagreb, Croatia
C.-R. Tania, V. Jovanovic, K. Zega, O. Kofman,
E. Binder, C. Brodski
